Investing Profile

Beth Seidenberg

VCInvestor

General Partner at Kleiner Perkins

kleinerperkins.com/people/bet...San Francisco, California
Photo of Beth Seidenberg, General Partner at Kleiner Perkins
Your Intro Paths to Beth Seidenberg

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Beth Seidenberg on

cb
Current Investing Position
Kleiner Perkins General Partner
Investment Range
$2.0M - $50.0M
Sweet Spot
$25.0M
Investments On Record
54
Current Fund Size
750M

Beth Seidenberg is on these Sector & Stage Rankings

Beth Seidenberg's Investments On Record (22)

CompanyStageDateRound SizeTotal Raised
ACELYRIN
Series CSep 2022$300M
Series BNov 2021$250M
Series ADec 2020$8M
$560M
Co-investors: Richard Gaster (venBio), Dan Becker (Access Biotechnology)
ArsenalBio
Series BSep 2022$220M
Series AOct 2019$85M
$310M
Neuron23
Series CMar 2022$100M
Series BDec 2020$80M
Series ADec 2020$34M
$210M
Electra Therapeutics
Series BFeb 2022$84M
$84M
Co-investors: Carl Gordon (OrbiMed)
Kyverna Therapeutics
Series BJan 2022$85M
Series AJan 2020$25M
$110M
Expansion Therapeutics
Series BSep 2021$80M
Series AJan 2018$55M
$140M
Co-investors: Scott Rocklage (5am Ventures), Andrew Levin (RA Capital)
Capsida
Series AApr 2021$50M
$50M
Co-investors: Clare Ozawa (Versant Ventures)
Sagimet Biosciences
Venture RoundFeb 2021$80M
Series EAug 2019$7M
Series DDec 2014$29M
Series CJun 2013$20M
Venture RoundOct 2012$8.1M
Venture RoundJan 2012$20M
Series BJul 2009$30M
$190M
Co-investors: Robert Garland (New Enterprise Associates (NEA)), Matthew McAviney (New Enterprise Associates (NEA)), David Mott (Mott Family Capital)